SCHEMBL25039645

SCHEMBL25039645

Cc1cc(NC2CCC(CN)CC2)cc(C)c1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 1/20 0.37
▸ KDM1A O60341 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ MAPK14 Q16539 1/20 0.33
▸ IRAK1 P51617 1/20 0.33
▸ CCNT1 O60563 4/20 0.32
▸ PABPC1 P11940 1/20 0.32
▸ TTK P33981 1/20 0.32
▸ PIM1 P11309 1/20 0.32
▸ PIM2 Q9P1W9 1/20 0.32
▸ MAPK6 Q16659 1/20 0.32
▸ AXL P30530 1/20 0.32
▸ FLT3 P36888 1/20 0.32
▸ TYRO3 Q06418 1/20 0.32
▸ MERTK Q12866 1/20 0.32
▸ GAS6 Q14393 1/20 0.32
▸ NCF1 P14598 1/20 0.31
▸ CNR2 P34972 3/20 0.31
▸ CNR1 P21554 1/20 0.31
▸ DYRK1A Q13627 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25041513 0.85 ALDH1A1 (0.43) BTKKDM1AMAOB
SCHEMBL30279242 0.85 ALDH1A1 (0.43) BTKKDM1AMAOB
SCHEMBL25041353 0.79 KDM1A (0.38) BTKKDM1AMAOBCCNT1FLT3
SCHEMBL25039457 0.77 RAPGEF4 (0.42) BTKKDM1AMAOBPIM1PIM2
SCHEMBL26325063 0.77 SMN1; SMN2 (0.42) CNR2CNR1
SCHEMBL29218647 0.76 USP2 (0.34) MAPK14CNR2CNR1
SCHEMBL12916487 0.74 KDM1A (0.53) BTKKDM1AMAOBCCNT1AXL
SCHEMBL25039260 0.71 KDM1A (0.39) KDM1AMAOBMELK
SCHEMBL25041988 0.71 NPC1 (0.45) KDM1AMAOB
SCHEMBL25040014 0.71 EPHX2 (0.42) KDM1AMAOBCNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240360114-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-31 — — US disclosed
EP-4384493-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd (KY) 2024-06-19 — — EP disclosed
CN-118076581-A Iron death modulators, their preparation and use 维泰瑞隆有限公司 2024-05-24 — — CN disclosed
WO-2023016447-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-02-16 — — WO disclosed
WO-2023016447-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-02-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240360114-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 BTK 3650/4885KDM1A 3776/4885MAOB 1677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback